dc.contributor.author |
Du Plessis, Tamarisk
|
|
dc.contributor.author |
Rae, William Ian Duncombe
|
|
dc.contributor.author |
Ramkilawon, Gopika
|
|
dc.contributor.author |
Ramkilawon, Gopika Devi
|
|
dc.contributor.author |
Martinson, Neil Alexander
|
|
dc.contributor.author |
Sathekge, Mike Machaba
|
|
dc.date.accessioned |
2024-05-15T12:16:40Z |
|
dc.date.available |
2024-05-15T12:16:40Z |
|
dc.date.issued |
2023-09-01 |
|
dc.description |
DATA AVAILABILITY STATEMENT : Data are available on request from the corresponding author. |
en_US |
dc.description.abstract |
Tuberculosis (TB) remains the second leading cause of death globally from a single infectious
agent, and there is a critical need to develop improved imaging biomarkers and aid rapid assessments
of responses to therapy. We aimed to utilize radiomics, a rapidly developing image analysis tool, to
develop a scoring system for this purpose. A chest X-ray radiomics score (RadScore) was developed
by implementing a unique segmentation method, followed by feature extraction and parameter
map construction. Signature parameter maps that showed a high correlation to lung pathology
were consolidated into four frequency bins to obtain the RadScore. A clinical score (TBscore) and a
radiological score (RLscore) were also developed based on existing scoring algorithms. The correlation
between the change in the three scores, calculated from serial X-rays taken while patients received TB
therapy, was evaluated using Spearman’s correlation. Poor correlations were observed between the
changes in the TBscore and the RLscore (0.09 (p-value = 0.36)) and the TBscore and the RadScore (0.02
(p-value = 0.86)). The changes in the RLscore and the RadScore had a much stronger correlation of
0.22, which is statistically significant (p-value = 0.02). This shows that the developed RadScore has
the potential to be a quantitative monitoring tool for responses to therapy. |
en_US |
dc.description.department |
Nuclear Medicine |
en_US |
dc.description.department |
Statistics |
en_US |
dc.description.librarian |
am2024 |
en_US |
dc.description.sdg |
SDG-03:Good heatlh and well-being |
en_US |
dc.description.sponsorship |
FUNDING : The APC was funded by the Department of Nuclear Medicine, University of Pretoria,
South Africa. |
en_US |
dc.description.uri |
https://www.mdpi.com/journal/diagnostics |
en_US |
dc.identifier.citation |
Du Plessis, T.; Rae, W.I.D.; Ramkilawon, G.; Martinson, N.A.; Sathekge, M.M. Quantitative Chest X-ray Radiomics for Therapy Response Monitoring in Patients with Pulmonary Tuberculosis. Diagnostics 2023, 13, 2842. https://DOI.org/10.3390/diagnostics13172842. |
en_US |
dc.identifier.issn |
2075-4418 (online) |
|
dc.identifier.other |
10.3390/diagnostics13172842 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/95995 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
MDPI |
en_US |
dc.rights |
© 2023 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license. |
en_US |
dc.subject |
Radiomics |
en_US |
dc.subject |
Segmentation |
en_US |
dc.subject |
Feature extraction |
en_US |
dc.subject |
Chest X-rays |
en_US |
dc.subject |
Radiomics score |
en_US |
dc.subject |
Tuberculosis (TB) |
en_US |
dc.subject |
SDG-03: Good health and well-being |
en_US |
dc.title |
Quantitative chest X-ray radiomics for therapy response monitoring in patients with pulmonary tuberculosis |
en_US |
dc.type |
Article |
en_US |